ROSAI-DORFMAN DISEASE
Clinical trials for ROSAI-DORFMAN DISEASE explained in plain language.
Never miss a new study
Get alerted when new ROSAI-DORFMAN DISEASE trials appear
Sign up with your email to follow new studies for ROSAI-DORFMAN DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo trial offers hope for rare immune disorder
Disease control Recruiting nowThis study is testing whether a combination of two existing drugs, lenalidomide and dexamethasone, can help control Rosai-Dorfman disease, a rare disorder where the immune system causes tissue damage. The trial will enroll 40 adults with the condition to see how well the treatmen…
Matched conditions: ROSAI-DORFMAN DISEASE
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Mar 31, 2026 12:18 UTC
-
New hope for Tough-to-Treat rare diseases: experimental drug targets faulty cell signals
Disease control Recruiting nowThis study is testing whether the drug cobimetinib can help control several rare disorders caused by overactive immune cells, particularly when standard treatments have failed. The trial will enroll 90 children and adults with conditions like Langerhans cell histiocytosis (LCH) a…
Matched conditions: ROSAI-DORFMAN DISEASE
Phase: PHASE2 • Sponsor: Carl Allen • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
New scan seeks to illuminate hidden cancers
Knowledge-focused Recruiting nowThis study is testing a new imaging agent used with PET/CT scans to see if it can better detect and measure certain blood cancers and rare tumors. It involves about 30 adult patients with conditions like non-Hodgkin lymphoma, multiple myeloma, or specific rare diseases. The goal …
Matched conditions: ROSAI-DORFMAN DISEASE
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC